Israel-based Teva and Samsung Bioepis have signed an agreement to jointly develop and commercialize up to six biosimilar candidates. Samsung Bioepis will handle development, regulatory activities and manufacturing, while Teva will be responsible for sales in the United States, Eu
9 days ago
AstraZeneca will invest $2 billion (about 2.68 trillion won) in Summit Therapeutics. With the investment, AstraZeneca will acquire a 12% stake in Summit and combine ivonescimab with its antibody-drug conjugates. AstraZeneca plans to develop combinations of ivonescimab and Datrowa
9 days ago
MedPacto received approval for its Phase 1 clinical trial plan in Australia for MP2021, an inhibitor of osteoclast formation. Australia’s Human Research Ethics Committee (HREC) approved a single-ascending-dose study to evaluate safety and tolerability in up to 32 healthy adults.
10 days ago
The Ministry of Food and Drug Safety said cosmetics exports totaled a provisional $11.1 billion through the third quarter of this year. That was a 31.1% increase from the same period last year and a record for the first three quarters. The ministry plans to continue regulatory co
10 days ago
Samsung Biologics has signed a contract to manufacture drugs for a pharmaceutical company based in Europe. The contract is valued at 93,478,620,000 won (about $68.75 million), equivalent to 2.05% of its consolidated revenue in 2025. The contract runs from Oct. 2, 2026, through De
10 days ago
SN BioScience passed the technology assessment for a special technology-based listing on the KOSDAQ. It received grades of A and BBB from the two specialized evaluation agencies designated by the Korea Exchange. SN BioScience plans to file for a preliminary listing review by the
10 days ago
Researchers at the Massachusetts Institute of Technology identified why a high-fat diet promotes the spread of colorectal cancer to the liver. Neuroceramides gave cancer cells the ability to metastasize without increasing the size of the primary tumor. The researchers said they h
10 days ago
U.S. researchers analyzed the impact of the Breast Cancer Index test in 2,900 patients with early-stage hormone receptor-positive breast cancer. The test predicts the benefit of extended therapy for patients who have completed 5 years of adjuvant endocrine therapy. After testing,
10 days ago
Researchers at the Icahn School of Medicine at Mount Sinai in the United States identified a pathway through which the Alzheimer’s disease risk gene APOE4 damages blood vessels. APOE4 transformed pericytes, which protect blood vessel walls, into fibrotic cells, making the vessels
10 days ago
The Ministry of Health and Welfare and the Korea Health Information Service visited Korea University Guro Hospital to review progress on real-world testing under the medical AI test bed support program. The program provides 4.8 billion won to evaluate the clinical effectiveness o
10 days ago
